14
as assigned by appointment letter, the following must also be achieved:
● Obtain an extramural peer-reviewed grant or contract as PI. Federal grants, contracts,
foundations, and industry funding apply (e.g., NIH, NSF, AHRQ, PCORI, CDC, CMS, NACDS,
etc.). The cumulative grant/contract funding must be at the R03 level or equivalent (i.e.,
~$100,000 in total direct costs).
● Submission of at least 1 grant/contract as PI, -with funding level and scope significantly
greater than ~$100,000 in total direct costs, e.g., multi-year funding, multi-site. The
submission must have received at least a promising review (e.g., for NIH or VA the grant
must be scored or encouraged to revise and resubmit). Federal grants, contracts,
foundations, and industry funding (e.g., NIH, DOD, AHRQ, PCORI, CDC, CMS, NACDS, etc.) all
meet these criteria. In the case a contract is submitted, not obtained, and feedback was not
provided, the candidate must provide convincing rationale for future funding.
Level 3: Establishes an independent, extramurally supported, nationally recognized scholarly
program
Must demonstrate the ability to sustain and grow an extramurally supported, nationally
recognized scholarly program by achieving all of the following:
● Publication of at least an additional 15 peer-reviewed papers (while in current rank), a
minimum of 7 as lead, senior, or corresponding author. Note that the impact of the
publications will be considered as well as the quantity. Quality must be addressed by the
faculty candidate and will be assessed by factors such as h-index and impact factor of
journals.
● Sustained funding for research, serving as PI on multiple peer-reviewed grants or contracts
as necessary to support and advance their research program. Obtained grants/contracts
need to be greater than ~$200,000 in direct cost for the area of research, as evidenced by
factors such as multi-year and/or multi-site research. Funding sources may include federal
grants, contracts, foundations, and industry funding (e.g., NIH, NSF, AHRQ, PCORI, CDC, CMS,
NACDS, American Heart Association, etc.). In case the funding levels are not consonant with
grants offered/awarded in the faculty member’s field, it is incumbent upon the candidate to
provide context regarding available funding.
● Regular presentations of scholarly/research activities at both national and international
conferences and symposia.
And achieve > 2 of the following criteria:
● Consulting at the national level on grants/contracts, or serving on national/international
advisory boards.
● Invitations to present plenary or other major keynote presentations at
national/international meetings
● Investigational new drugs or other technologies approved by the FDA
● Drug(s) approved for clinical development (IND)
● Perform innovative research as evidenced by patent issued, publications recognized for
excellence and/or impact and/or copyrighted material (e.g., software, tools), as is consistent
with the area of science
● Invitation to serve as a regular member of a major federal or equivalent study section (grant